NEW YORK (
CHANGE IN RATINGS
American Equity Investment
upgraded to buy at TheStreet Ratings.
downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $40 price target. Company may struggle to maintain recent growth momentum.
Bank of America
downgraded at Baird from Outperform to Neutral, Robert Baird said. $10 price target. Valuation call, as the stock has gained 80% year-to-date.
Buffalo Wild Wings
downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $100 price target.
Brookfield Office Properties
upgraded to buy at TheStreet Ratings.
rated new Buy at Stifel. $21 price target. Star Wars can drive growth over the coming quart.
First Republic Bank
rated new Outperform at BMO Capital Markets. $39 price target. Differentiated by high levels of client service.
downgraded at Lazard from Buy to Neutral, Lazard said. Company lacks material growth drivers.
upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. Valuation call, based on a $43 price target.
upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $29.60 price target. Company is leveraged to higher demand from China.
upgraded at UBS to Buy from Neutral, UBS said. $36 price target. Higher growth outlook and improved guidance.
STOCK COMMENTS / EPS CHANGES
target raised at Think to $700, ThinkEquity said. Positive launch of the new iPad and strong upcoming products. Buy rating.
target increased at Citigroup to $110, Citigroup said. Pipeline supports sustainable long term growth. Buy rating.
estimates cut at Jefferies through 2013, Jefferies said. New starts outlook in uninspiring. Perform rating.
estimates, target raised at Morgan Stanley. Shares of BWA now seen reaching $100, according to Morgan Stanley. Estimates also increased, as the company can continue to expand margins. Overweight rating.
estimates, target boosted at Morgan Stanley. Shares of CTAS now seen reaching $32, according to Morgan Stanley. Estimates also upped, as the company is seeing higher sales and keeping a lid on costs. Underweight rating.
estimates upped at Guggenheim through 2013, Guggenheim said. Company is buying back more stock. Buy rating and $54 price target.
estimates increased at Morgan Stanley through 2013, Morgan Stanley said. Domestic sales continue to increase. Overweight rating and $18 price target.
numbers upped at Jefferies. FINL estimates were boosted through 2013, Jefferies said. Solid sales growth should drive higher margins. Buy rating and new $29 price target.
numbers raised at BofA/Merrill. Shares of JPM now seen reaching $52, according to Bank of America/Merrill Lynch said. Estimates also increased, given better core trading and mortgage banking revenue.
estimates raised at Goldman through 2014, Goldman Sachs said. Significant contribution from Katz Group acquisition. Buy rating.
numbers raised at Benchmark.Shares of MHP now seen reaching $52, according to Benchmark. Estimates also increased, given a better environment for bond issuances. Hold rating.
target raised at UBS to $54, UBS said. See upside to Q4 billings. Neutral rating.
upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $48 price target. Acceptance kiosks can help drive near-term growth.
target boosted at Credit Suisse to $49, according to Credit Suisse. Domestic volumes should improve in 2012. Outperform rating.
target raised at ThinkEquity to $36, according to ThinkEquity. Company can continue to generate solid salse growth. Buy rating.
estimates, target increased at Credit Suisse. VRSK estimates were raised through 2013, Credit Suisse said. MediConnect deal should add to earnings. Outperform rating and new $53 price target.
>To submit a news tip, email:
and become a fan on
This article was written by a staff member of TheStreet.